首页> 美国卫生研究院文献>Epidemiologic Perspectives Innovations : EP+I >Flexible Two-Phase studies for rare exposures: Feasibility planning and efficiency issues of a new variant
【2h】

Flexible Two-Phase studies for rare exposures: Feasibility planning and efficiency issues of a new variant

机译:灵活的两阶段研究针对稀有风险:新变体的可行性计划和效率问题

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The two-phase design consists of an initial (Phase One) study with known disease status and inexpensive covariate information. Within this initial study one selects a subsample on which to collect detailed covariate data. Two-phase studies have been shown to be efficient compared to standard case-control designs. However, potential problems arise if one cannot assure minimum sample sizes in the rarest categories or if recontact of subjects is difficult.In the case of a rare exposure with an inexpensive proxy, the authors propose the flexible two-phase design for which there is a single time of contact, at which a decision about full covariate ascertainment is made based on the proxy. Subjects are screened until the desired numbers of cases and controls have been selected for full data collection. Strategies for optimizing the cost/efficiency of this design and corresponding software are presented. The design is applied to two examples from occupational and genetic epidemiology. By ensuring minimum numbers for the rarest disease-covariate combination(s), we obtain considerable efficiency gains over standard two-phase studies with an improved practical feasibility.The flexible two-phase design may be the design of choice in the case of well targeted studies of the effect of rare exposures with an inexpensive proxy.
机译:分为两个阶段的设计包括具有已知疾病状态和廉价协变量信息的初始(第一阶段)研究。在这项初步研究中,我们选择了一个子样本以收集详细的协变量数据。与标准的病例对照设计相比,两阶段研究已被证明是有效的。但是,如果不能确保最稀有类别中的最小样本量或难以重新接触受试者,就会出现潜在的问题。在使用廉价代理进行罕见曝光的情况下,作者提出了灵活的两阶段设计一次接触,根据代理决定完全协变量确定。对受试者进行筛选,直到选择了所需数量的病例和对照进行完整的数据收集为止。提出了优化该设计的成本/效率和相应软件的策略。该设计应用于职业和遗传流行病学的两个例子。通过确保最稀有疾病/协变量组合的最小数量,我们在标准两阶段研究中获得了可观的效率提升,并且具有更高的实际可行性。灵活的两阶段设计可能是针对性强的情况下的选择设计用廉价的代理人研究罕见暴露的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号